title: Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets.
abstract: The European Society of Hypertension recommend the following main rules for treatment of hypertension in elderly and octogenarians: 1) In elderly hypertensives with SBP ≥ 160 mmHg there is solid evidence to recommend reducing SBP to between 140 mmHg and 150 mmHg. 2) In fit elderly patients less than 80 years old treatment may be considered at SBP ≥ 140 mmHg with a target SBP < 140 mmHg if treatment is well tolerated. 3) In fit individuals older than 80 years with an initial SBP ≥ 160 mmHg it is recommended to reduce SBP to between 150 mmHg and 140 mmHg. 4) In frail elderly patients, it is recommended to base treatment decisions on comorbidity and carefully monitor the effects of treatment. 5) Continuation of well-tolerated antihypertensive treatment should be considered when a treated individual becomes octogenarian. 6) All hypertensive agents are recommended and can be used in the elderly, although diuretics and calcium antagonists may be preferred in isolated systolic hypertension.
authors.affiliation: a Departments of Cardiology and Nephrology , Oslo University Hospital , Ullevål.|b Faculty of Medicine , University of Oslo , Oslo , Norway.
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.affiliation: a Departments of Cardiology and Nephrology , Oslo University Hospital , Ullevål.
authors.forename: Aud
authors.initials: A
authors.lastname: Stenehjem
authors.affiliation: a Departments of Cardiology and Nephrology , Oslo University Hospital , Ullevål.|b Faculty of Medicine , University of Oslo , Oslo , Norway.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Os
authors.affiliation: c Hôpital Erasme - ULB, Cliniques Universitaires de Bruxelles , Bruxelles , Belgium.
authors.forename: Philippe
authors.initials: P
authors.lastname: Van de Borne
authors.affiliation: d Service of Nephrology and Hypertension , Centre Hospitalier Universitaire Vaudois , Lausanne , Switzerland.
authors.forename: Michel
authors.initials: M
authors.lastname: Burnier
authors.affiliation: e Department of Hypertension and Diabetology , Medical University of Gdansk , Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Narkiewicz
authors.affiliation: f Department of Internal Medicine , Hospital Clinico, University of Valencia , Valencia , Spain.
authors.forename: Josep
authors.initials: J
authors.lastname: Redon
authors.affiliation: g Clinica Medica, Department of Clinical and Experimental Sciences , University of Brescia , Brescia , Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Agabiti Rosei
authors.affiliation: h University of Milano-Bicocca , Milan , Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Mancia
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure; D005060:Europe; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000628:therapy*
keywords: Blood pressure-lowering treatment; European Society of Hypertension; blood pressure targets; elderly patients; octogenarians